AMWL

American Well Corp

AMWL, USA

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members. It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

https://business.amwell.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
AMWL
stock
AMWL

Can AMWL stock deliver strong annual returns - July 2025 Opening Moves & Weekly High Return Opportunities Улправда

Read more →
AMWL
stock
AMWL

New Analyst Forecast: $AMWL Given $6 Price Target Quiver Quantitative

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

HOLD

Target Price:

$8.125

Analyst Picks

Strong Buy

1

Buy

0

Hold

8

Sell

0

Strong Sell

0

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.30

Low 1

High 3

Return on Equity (ROE)

-

Very Low

-12.70 %

Low 5%

High 25%

Return on Assets (ROA)

-

Very Low

-9.01 %

Low 2%

High 10%

Free Cash Flow - Revenue % (FCF)

-

Very Low

-33.34 %

Low 5%

High 15%

Debt to Equity

-

Very High

0.36

Low 1

High 0.3

Investors

* Institutions hold a combined 33.41% of the total shares of American Well Corp

1.

RIMA MANAGEMENT, LLC

(8.1281%)

since

2025/06/30

2.

Morgan Stanley - Brokerage Accounts

(7.6579%)

since

2025/06/30

3.

Caledonia (Private) Investments Pty Ltd

(5.0071%)

since

2025/06/30

4.

Vanguard Group Inc

(3.9271%)

since

2025/06/30

5.

BlackRock Inc

(1.5149%)

since

2025/06/30

6.

Renaissance Technologies Corp

(1.0861%)

since

2025/06/30

7.

Rock Point Advisors, LLC

(1.0747%)

since

2025/06/30

8.

Geode Capital Management, LLC

(0.9135%)

since

2025/06/30

9.

Millennium Management LLC

(0.6972%)

since

2025/06/30

10.

Bridgeway Capital Management, LLC

(0.5989%)

since

2025/06/30

11.

Takeda Pharmaceutical Co Ltd

(0.4813%)

since

2025/06/30

12.

Dimensional Fund Advisors, Inc.

(0.4432%)

since

2025/06/30

13.

State Street Corp

(0.3003%)

since

2025/06/30

14.

Susquehanna International Group, LLP

(0.2532%)

since

2025/06/30

15.

Squarepoint Ops LLC

(0.253%)

since

2025/06/30

16.

Two Sigma Investments LLC

(0.2339%)

since

2025/06/30

17.

HighTower Advisors, LLC

(0.232%)

since

2025/06/30

18.

Two Sigma Advisers, LLC

(0.2182%)

since

2025/06/30

19.

Citadel Advisors Llc

(0.201%)

since

2025/06/30

20.

Jane Street Group LLC

(0.1896%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

No earnings data available.

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(6.5)
Defensive
Highly Defensive(7)
Dividend
Weak Dividend Profile(1.5)
Economic Moat
Some Competitive Advantage(4.3)
GARP
Not Attractive for GARP(2.5)
Growth
Weak Growth Prospect(1)
Momentum
No Momentum(3)
Net Net
Strong Net-Net(8)
Quality
Low Quality Business(2.5)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.